Skip to main content Accessibility help
×
Home

Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes

  • Jeffrey L. Jackson, Patrick G. O'Malley and Kurt Kroenke

Abstract

Somatic symptoms are common in primary care and clinicians often prescribe antidepressants as adjunctive therapy. There are many possible reasons why this may work, including treating comorbid depression or anxiety, inhibition of ascending pain pathways, inhibition of prefrontal cortical areas that are responsible for “attention” to noxious stimuli, and the direct effects of the medications on the syndrome.There are good theoretical reasons why antidepressants with balanced norepinephrine and serotonin effects may be more effective than those that act predominantly on one pathway, though head-to-head comparisons are lacking. For the 11 painful syndromes review in this article, cognitive-behavioral therapy is most consistently demonstrated to be effective, with various antidepressants having more or less randomized controlled data supporting or refuting effectiveness.This article reviews the randomized controlled trial data for the use of antidepressant and cognitive-behavior therapy for 11 somatic syndromes: irritable bowel syndrome, chronic back pain, headache, fibromyalgia, chronic fatigue syndrome, tinnitus, menopausal symptoms, chronic facial pain, noncardiac chest pain, interstitial cystitis, and chronic pelvic pain. For some syndromes, the data for or against treatment effectiveness is relatively robust, for many, however, the data, one way or the other is scanty.

Copyright

Corresponding author

Please direct all correspondence to: Jeffrey L. Jackson, MD, MPH, Uniformed Services University of the Health Sciences, Medicine-EDP, 4301 Jones Bridge Road, Bethesda, MD 20814; Tel: 202-782-5603, Fax: 202-782-7363; E-mail: jejockson@usuhs.mil.

References

Hide All
1.Whitehead, WE, Palsson, O, Jones, KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:11401156
2.Lake, AE 3rd, Rains, JC, Penzien, DB, Lipchik, GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45:493506.
3.Patten, SB, Beck, CA, Kassam, A, Williams, JV, Barbui, C, Metz, LM. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry. 2005;50:195202.
4.Bonaz, B, Baciu, M, Papillon, E, et al.Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654656.
5.Drossman, DA, Toner, BB, Whitehead, WE, et al.Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:1931.
6.Jackson, JL. Somatic and vegetative symptoms in depression. Depression, Mind and Body. 2004;1:4249.
7.Damatarca, C. Pain and depression: bridging the body and mind. Depression, Mind and Body. 2003;1:713.
8.Jones, SL. Descending noradrenergic influences on pain. Prog Brain Res. 1991;88:391394.
9.Richardson, BP. Serotonin and nocioception. Ann N Y Acad Sci. 1990;600:511519.
10.Stahl, SM. The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry. 2002;63:382383.
11.Willis, WD, Westlund, KN. Neuroanatomy of the pain system and the pathways that modulate pain. J Clin Neurophysiol. 1997;14:231.
12.Naliboff, BD, Munakata, J, Fullerton, S, et al.Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41:505512.
13.Petzke, F, Harris, RE, Williams, DA, Clauw, DJ, Gracely, RH. Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls. Eur J Pain. 2005;9:325335.
14.Montoya, P, Pauli, P, Batra, A, Wiedemann, G. Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain. 2005;9:293303.
15.Gorard, DA, Libby, GW, Farthing, MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:159166.
16.Kroenke, K, Swindle, R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205215.
17.Allen, LA, Escobar, JL, Lehrer, PM, Gara, MA, Woolfolk, RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med. 2002;64:939950.
18.Lackner, JM, Lou Coad, M, Mertz, HR, et al.Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, Gl symptoms, and anxiety. Behav Res Ther. 2005 Jul 20; [Epub ahead of print].
19.Brandt, LJ, Bjorkman, D, Fennerty, MB, Locke, GR, Olden, K, Peterson, Wet al.Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 suppl):S7S26.
20.Thompson, WG, Heaton, KW, Smyth, GT, Smyth, C. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol. 1997;9:689692.
21.Gladman, LM, Gorard, DA. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders. Aliment Pharmacol Ther. 2003;17:651654.
22.American College of Gastroenterology Functional Gastrointestinal Disorders Task Froce. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 Suppl):S1S5.
23.Guilera, M, Balboa, A, Mearin, F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol. 2005;100:11741184.
24.Koloski, NA, Talley, NJ, Boyce, PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001;96:13401349.
25.Clouse, RE. Antidepressants for irritable bowel syndrome. Gut. 2003;52:598599.
26.Lesbros-Pantoflickova, D, Michetti, PFried, M, Beglinger, C, Blum, AL. Meta-analysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20:1253–69.
27.Jailwala, J, Imperiale, TF, Kroenke, K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000;133:136147.
28.Jackson, JL, O'Malley, PG, Tomkins, G, Balden, E, Santoro, J, Kroenke, K. Treatment of functional gastrointestinal disorders with antidepressant medications: a metaanalysis. Am J Med. 2000;108:6572.
29.Kazis, LE, Anderson, JJ, Meenan, RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(3 suppl):S178S189.
30.Tabas, G, Beaves, M, Wang, J, Friday, P, Mardini, H, Arnold, G. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial. Am J Gastroenterol. 2004;99:914920.
31.Kuiken, SD, Tytgat, GN, Boeckxstaens, GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol. 2003;1:219228
32.Toner, BB, Segal, ZV, Emmot, S, et al.Cognitive-behavioral group therapy for patients with irritable bowel syndrom. Int J Group Psychother. 1998;48:215243.
33.Hutton, J. Cognitive behaviour therapy for irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17:1114
34.Kennedy, T, Jones, R, Darnley, S, Seed, RWessely, S, Chalder, T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ. 2005;331:435.
35.Shaw, G, Srivastava, ED, Sadlier, M, Swann, P, James, JY, Rhodes, J. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:3642.
36.Bennett, P, Wilkinson, S. A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psychol. 1985;24(pt3):215216.
37.Heymann-Monnikes, I, Arnold, R, Florin, I, Herda, C, Melfsen, S, Monnikes, H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981994.
38.Boyce, PM, Talley, NJ, Balaam, B, Koloski, NA, Truman, G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003;98:22092218.
39.Hart, LG, Deyo, RA, Cherkin, DC. Hart, LG, Deyo, RA, Cherkin, DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine. 1995;20:1119.
40.Maniadakis, N, Gray, A. The economic burden of back pain in the UK. Pain. 2000;84:95103.
41.Von Korff, M, Saunders, K. The course of back pain in primary care. Spine. 1996;21:28332837.
42.Salerno, SM, Browning, R, Jackson, JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med. 2002;162:1924.
43.Staiger, TO, Gaster, B, Sullivan, MD, Deyo, RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003;28:25402545.
44.Schnitzer, TJ, Ferraro, A, Hunsche, E, Kong, SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. J Pain Symptom Manage. 2004;28:7295.
45.Jenkins, DG, Ebbutt, AF, Evans, CD. Tofranil in the treatment of low back pain. J Int Med Res. 1976;4(2 Suppl):2840.
46.Alcoff, J, Jones, E, Rust, Ret al.Controlled trial of imipramine for chronic low back pain. J Fam Pract. 1982;14:841846.
47.Pheasant, H, Bursk, A, Goldfarb, J, et al.Amitriptyline and chronic low-back pain. A randomized doubleblind crossover study. Spine. 1983;8:552557.
48.Goodkin, K, Gullion, CM, Agras, WS. A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol. 1990;10:269278.
49.Atkinson, JH, Slater, MA, Williams, RA, et al.A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76:287296.
50.Atkinson, JH, Slater, MA, Wahlgren, DR, et al.Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain. 1999;83:137145.
51.Dickens, C, Jayson, M, Sutton, C, Creed, F. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics. 2000;41:490499.
52.Ward, N, Bokan, JA, Phillips, M, Benedetti, C, Butler, S, Spengler, D. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry. 1984;45(3 pt 2):5459.
53.Schreiber, S, Vinokur, S, Shavelzon, V, Pick, CG, Zahavi, E, Shir, Y. A randomized trial of fluoxetine versus amitriptyline in musculoskeletal pain. Isr J Psychiatry Relat Sci. 2001;38:8894.
54.Hameroff, SR, Weiss, J, Lerman, JC. et al.Doxepin's effects on chronic pain and depression. J Clin Psychiatry. 1984;45(3 pt 2):4752.
55.O'Malley, PG, Jackson, JL, Tomkins, G, Santoro, J, Balden, E, Kroenke, K. Antidepressant therapy for unexplained symptoms and symptom syndromes: a critical review. J fam Pract. 1999;48:980993.
56.Jung, AC, Staiger, T, Sullivan, M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997;12:384389.
57.Onghena, RVan Houdenhove, B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992;49:205219.
58.Grothe, DR. Scheckner, B, Albano, D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy. 2004;24:621629.
59.Raine, R, Haines, A, Sensky, T, Hutchings, A, Larkin, K, Black, N. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care? BMJ. 2002;325:1082.
60.van Tulder, MW, Koes, BW, Bouter, LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine. 1997;22:21282156.
61.Lorig, KR, Holman, H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:17.
62.Rasmussen, BK, Olesen, J. Epidemiology of headache in a general population: a prevalence study. Curr Opin Neurol. 1994;7:264–227.
63.Hu, XH, Markson, LE, Lipton, RB, Stewart, WF, Berger, ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813818.
64.Taylor, FR. Diagnosis and classification of headache. Prim Care. 2004;31:243259.
65.Lake, AE 3rd, Rains, JC, Penzien, DB, Lipchik, GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45:493506.
66.Gesztelyi, G, Bereczki, D. Disability is the major determinant of the severity of depressive symptoms in primary headaches but not in low back pain. Cephalalgia. 2005;25:598604.
67.Torelli, P, D'Amico, D. An updated review of migraine and co-morbid psychiatric disorders. Neurol Sci. 2004;25(suppl 3):S234S235.
68.Tomkins, GE, Jackson, JL, O'Malley, PG, Balden, E, Santoro, JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med. 2001;111:5463.
69.Lance, JW, Curran, DA. Treatment of chronic tension headache. Lancet. 1964;1:12361239.
70.Moja, PL, Cusi, C, Sterzi, RR, Canepari, C. Selective Serotonin Re-uptake Inhibitors for Preventing Migraine and Tension-Type Heaches. Cochrane Database Syst Rev. 2005:CD002919.
71.Rains, JC, Penzien, DB, McCrory, DC, Gray, RN. Behavioral Headache Treatment: History, Review of the Empirical Literature, and Methodological Critique. Headache. 2005;45(suppl 2):S92S109.
72.Linde, K, Rossnagel, K. Propranolol for migraine prophylaxis. Cochrane Database Syst flev. 2004;(4):CD003225.
73.Melchart, D, Streng, A, Hoppe, A, et al.Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ. 2005;331:376382.
74.Silberstein, SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754762.
75.Schrader, H, Stovner, LJ, Helde, G, Sand, T, Bovim, G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001;322:1922.
76.Tronvik, E, Stovner, LJ, Helde, G, Sand, T, Bovim, G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289:6569.
77.Ernst, E. Manual therapies for pain control: chiropractic and massage. Clin J Pain. 2004;20:812.
78.Yunus, MD, Kalayan-Raman, UP, Masi, AT, Aldag, AT. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol. 1989;16:97–10
79.Simms, RW, Roy, SH, Hrovat, M, et al.Lack of association between fibromyalgia syndrome and abnormalities and muscle energy metabolism. Arthritis Rheum. 1994;37:794800.
80.Pillemer, SR, Bradley, LA, Crofford, LJ, Moldofsky, H, Chrousos, GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum. 1997;40:19281939
81.Wolfe, F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:117
82.Goldenberg, DL, Burckhardt, C, Crofford, L. Management of fibromyalgia syndrome. JAMA. 2004;292:23882395.
83.Arroyo, JF, Cohen, ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 1993;20:19251931.
84.Kosek, E, Ekholm, J, Hansson, PModulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain. 1996;64:415423.
85.Kosek, E, Ekholm, J, Hansson, P. Increased pressure pain sensibility in fibromyalgia patients is located deep in the skin but not restricted to muscle tissue. Pain. 1995;63:335339.
86.Drewes, AM, Gade, K, Nielsen, KD, Bjerregard, K, Taagholt, SJ, Svendsen, L. Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol. 1995;34:11511156.
87.May, KRWest, SG, Baker, MR, Everett, DW. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med. 1993;94:505508.
88.Yunus, MB, Aldag, JC. Restless leg syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.
89.MacFarlane, JG, Shahal, B, Mously, C, Moldofsky, H. Periodic K-alpha sleep EEG activity and periodic limb movements during sleep: comparisons of clinical features and sleep parameters. Sleep. 1996;19:200204.
90.Hudson, JL, Goldenberg, DL, Pope, HG Jr, Keck, PE Jr, Schlesinger, L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363367.
91.Triadafilopoulos, G, Simms, RW, Goldenberg, DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci. 1991;36:5964.
92.Ahles, TA, Khan, SA, Yunus, MB, Spiegell, DA, Masi, AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry. 1991;148:17211726.
93.O'Malley, PG, Balden, E, Tomkins, G, Santoro, J, Kroenke, K, Jackson, JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med. 2000;15:659666.
94.Goldenberg, D, Mayskiy, M, Mossey, C, Ruthazer, R, Schmid, C. A randomized, double-blind, crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:18521859.
95.Carette, S, McCain, GA, Bell, DA, Fam, AG. Evaluation of amitriptyline in primary fibro-sitis. A double-blind placebo-controlled study. Arthritis Rheum. 1986;29:655659.
96.Hannonen, P, Malminiemi, K, Yli-Kerttula, U, Isomeri, R, Roponen, P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol. 1998;37:12791286.
97.Wolfe, F, Cathey, MA, Hawley, DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255259.
98.Norregaard, J, Volkmann, H, Danneskiold-Samsoe, B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445449.
99.Arnold, LM, Hess, EV, Hudson, JL, Welge, JA, Berno, SE, Keck, PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191197.
100.Arnold, LM, Lu, Y, Crofford, LJ, et al.A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:29742984.
101.Williams, DA. Psychological and behavioural therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003;17:649665.
102.Hadhazy, VA, Ezzo, J, Creamer, P, Berman, BM. Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol. 2000;27:29112918.
103.Tofferi, JK, O'Malley, PG, Jackson, JL. Treatment of fibromyalgia with cyclobenzap-rine: A meta-analysis. Arthritis Rheum. 2004;51:913.
104.Sharpe, M, O'Malley, PG. Chronic fatigue and fibromyalgia syndromes. In: Levinson, J, ed. Textbook of Consultation-Liaison Psychiatry, 1st ed. Washington, DC: American Psychiatric Press; 2004;108134
105.Fukuda, K, Straus, SE, Hickie, IB, Sharpe, M, Dobbins, JG, Komaroff, AL. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953959.
106.Sullivan, PF, Pedersen, NL, Jacks, A, Evengard, B. Chronic fatigue in a population sample: definitions and heterogeneity. Psychol Med. 2005;35:13371348.
107.Darbishire, L, Ridsdale, L, Seed, PT. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. Br J Gen Pract. 2003;53:441445.
108.Whiting, P, Bagnall, AM, Sowden, AJ, Cornell, JE, Mulrow, CD, Ramirez, G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA. 2001;286:13601368.
109.Natelson, BH, Cheu, J, Pareja, J, Ellis, SRPolicastro, T, Findley, TW. Randomized, bouble blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology. 1996;124:226230.
110.Vercoulen, JH, Swanink, CM, Zitman, FG, et al.Randomized double-blind placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet. 1996;347:858861.
111.Hickie, IB, Wilson, AJ, Wright, JM, Bennet, BK, Wakefield, D, Lloyd, AR. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry. 2000;61:643648.
112.Wearden, AJ, Morriss, RK, Mullis, R, et al.Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry. 1998;172:485490.
113.Sharpe, M, Hawton, K, Simkin, S, et al.Cognitive behavior therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ. 1996; 12:2226.
114.Deale, AChalder, XMarks, I, Wessely, S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry. 1997;154:408414.
115.Lloyd, AR, Hickie, I, Brockman, A, et al.Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med. 1993;94:197203.
116.Friedberg, F, Krupp, LB. A comparison of cognitive behavior treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis. 1994;18(suppl 1):S105S110.
117.Stulemeijer, M, de Jong, LW, Fiselier, TJ, Hoogveld, SW, Bleijenberg, G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ. 2005;330:14.
118.Huibers, MJ, Beurskens, AJ, Van Schayck, CP, et al.Efficacy of cognitive-behavioural therapy by general practitioners for unexplained fatigue among employees: randomised controlled trial. Br J Psychiatry. 2004;184:240246.
119.Ridsdale, L, Darbishire, L, Seed, PT. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care. Psychol Med. 2004;34:3749.
120.Deale, A, Husain, K, Chalder, T, Wessely, S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry. 2001;158:20382042.
121.Sullivan, M, Katon, W, Russo, J, Dobie, R, Sakai, C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med. 1993;153:22512259.
122.Mihail, RC, Crowley, JM, Walden, BE, Fishburne, J, Reinwall, JE, Zajtchuk, JT. The tricyclic trimipramine in the treatment of subjective tinnitus. Ann Otol Rhinol Laryngol. 1988;97:120123.
123.Kroner-Herwig, B, Frenzel, A, Fritsche, G, Schilkowsky, G, Esser, G. The management of chronic tinnitus: comparison of an outpatient cognitive-behavioral group training to minimal-contact interventions. J Psychosom Res. 2003;54:381389.
124.Zachriat, C, Kroner-Herwig, B. Treating chronic tinnitus: comparison of cognitive-behavioural and habituation-based treatments. Cogn Behav Ther. 2004;33:187198.
125.Andersson, G, Lyttkens, L. A meta-analytic review of psychological treatments for tinnitus. Br J Audiol. 1999;33:201210.
126.Stearns, V, Beebe, KL, Iyengar, M, Dube, E. Paroxetine controlled release in the treatment of menopausal hot flashers: a randomized controlled trial. JAMA. 2003;289:28272834.
127.Evans, ML, Pritts, E, Vittinghoff, E, McClish, K, Morgan, KS, Jaffe, RB. Management of postmenopausal hot flashes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol. 2005;105:161166.
128.Loprinzi, CL, Kugler, JW, Sloan, JA, et al.Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356:20592063.
129.Feinmann, C, Harris, M, Cawley, R. Psychogenic facial pain: presentation and treatment. Br Med J (Clin Res Ed). 1984;288:436438.
130.Cannon, RO, Quyyumi, AA, Mincemoyer, R, et al.Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;30:14111417.
131.Kisely, S, Campbell, LA, Skerritt, P. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2005:CD004101.
132.van Ophoven, A, Pokupic, S, Heinecke, A, Hertle, L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533536.
133.Engel, CC Jr, Walker, EA, Engel, AL, Bullis, J, Armstrong, A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res. 1998;44:203207.
134.Henningsen, RZimmermann, T, Sattel, H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528533.

Related content

Powered by UNSILO

Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes

  • Jeffrey L. Jackson, Patrick G. O'Malley and Kurt Kroenke

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.